5 results
nejm im cgrp fremanezumab migraine neuro adverseevents africa endo feast ivfluids pediatrics primarycare results romosozumab trial visualabstract
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
Romosozumab or Alendronate ... Nonvertebral Fracture #EBM ... PrimaryCare #Endo #IM ... #Romosozumab #Alendronate ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... Migraine #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... Migraine #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... Migraine #CGRP #CalcitoninGeneRelatedPeptideAntibody ... AdverseEvents #NEJM ... #NEJM
Mortality after Fluid Bolus in African Children with Severe Infection - June 30, 2011 N Engl
Mortality after Fluid Bolus ... CONCLUSIONS: Fluid boluses ... NEJMoa1101549 #EBM ... #Peds #Pediatrics ... #Africa #NEJM #
No results found for "Euglycemic+ebm+nejm+im peds boluses ebm calcitoningenerelatedpeptideantibody alendronate"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Euglycemic+ebm+nejm+im #peds #boluses #ebm #calcitoningenerelatedpeptideantibody #alendronate